Introduction
The crucial role of IL-4 in the regulation of IgE synthesis has been well established by studying mice that were made IL-4 deficient by gene targetting. No IgE synthesis was observed in these mice upon nematode infection [l] . Disrupting the IL-4 gene did not completely impair the IgGl production [l] , indicating that IL-4 is not an absolute requirement for IgGl. Functional studies have indicated IL-4 as a "switch-inducing factor" for both IgGl and IgE. It alters the chromatine structure of the Syl region [2] and induces accumulation of germ-line y1 and E transcripts (3, 41 , events that are associated with isotype class switching [ S , 61.
In line with these results is the observation that IL-4 enhances the IgGl production, although less IL-4 is [I 127681 required for peak IgGl responses than for peak IgE responses after LPS stimulation of B cells in vitro [7] . The role of cytokines other than IL-4 in in vivo polyclonal and antigen-specific IgGl and IgE responses has not been well investigated. In the human system, IL-6 has been described as a cytokine that is involved in the IL-4-dependent IgE synthesis (10, 111 . Similar observations were made in mice, in that neutralization of IL-6 resulted in a inhibition of the number of IgE-secreting cells in the spleen [12] . Surprisingly, in that study an inhibition of the number of IgE-secreting cells was also observed when IL-6 was administered [ 121.
Because of these contradictory results we decided to study the role of both IL-4 and IL-6 in IgGl and IgE responses. In the study of Auci et al. [12] antigen had been given more than once. It is known that memory IgE responses differ from primary IgE responses with respect to their IL-4 requirement, in that memory IgE responses are partially IL-4 independent [13-151. Therefore, we studied the effect of neutralizing IL-6 in vivo on memory IgGl and IgE responses as well as the effect of this treatment on polyclonal and antigen-specific primary IgGl and IgE responses. We also studied in in vitro cultures of splenic B cells whether IL-6 could enhance IgGl and/or IgE production.
OO14-2980/94/O606-1396$10 .OO + . 25/0 shown to be sufficient to neutralize the respective cytokine activities in a variety of systems. All the used hybridoma cells were assayed for their rat IL-6 production, and it was found that in all cases the average IL-6 production by 2 x lo6 hybridoma cells/day was less than 8 U. This production was determined in a bioassay using B9 indicator cells as described [23] , with a detection limit of 0.1 U/ml. Collectively, our results show that IgGl and IgE responses not only differ in IL-4 dependence, but also deviate with respect to IL-6 in attaining peak levels. This finding thus provides a second regulatory mechanism of IgGl and IgE responses coupled through sequential isotype switching.
Materials and methods

Mice
Female BALB/c mice were bred and maintained at the Department of Immunology of the Erasmus University. All mice were at an age of 12-16 weeks at the start of the experiments. The experiments were approved by the Animal Experiments Committee of the Erasmus University.
Immunization and infection
Mice were injected with 0.2 ml containing 10 yg TNP25-KLH adsorbed on 2 mg alum i.p. [15] or 800 yg goat anti-mouse (GAM) IgD (Nordic Immunology,Tilburg,The Netherlands) i.v. or were infected with Nippostrongylus brusiliensis (Nb; a kind gift of Dr. R. L. Coffman, DNAX, Palo Alto, CA) by subcuteneously injecting 750 stage 111 Nb larvae, as indicated in Sect. 3.4
Isotype-specific ELISA
Total serum IgE and IgGl levels were measured by isotype-specific ELISA as described previously [15, 161. Detection limits for the IgE and IgGl ELISA were 0.5 ng/ml and 0.2 ng/ml, respectively. TNP-specific IgGl and IgE were determined as previously described [15] , with 0.2 nglml and 1 nglml as detection limit in the ELISA, respectively. Total serum IgGz, and IgM were determined essentially in the same way using either GAM IgGz, (Southern Biotechnology, Birmingham, AL) or GAM IgM (Southern Biotechnology) both at 1 pg/ml as coat and biotinylated GAM IgGza or biotinylated GAM IgM both at 0.5 pglrnl as second step,with a detection limit of 0.3 ng/ml and 0.2 ng/ml, respectively.
Anti-cytokine treatment
Mice were treated in vivo by i.p. injection of purified neutralizing antibodies directed to IL-4 (11B11, rat IgGI, 10 mg/mouse) [17] , IL-5 (TRFKS, rat IgGl 2 mg/ml) [18] and IL-6 (20F3, rat IgGl, 2 mg/ml) [19] . Alternatively, mice were implanted with 2 x lo6 alginate-encapsulated 11B11 and/or 20F3 hybridoma cells i.p. [20] . The hybridoma cells encapsulated in alginate were implanted in mice 3 days before immunization, the purified antibodies were given 2 h before immunization. The rat IgGl production by these l l B l l and/or 20F3 cells was determined in the serum using a rat IgG1-specific ELISA as described previously [20] . Purified rat mAb specific for E. coli P-galactosidase (GL113) [21] or 2 x lo6 alginate-encapsulated GL113 cells were used as an IgGl isotype control. The mAb were purified from culture supernatants by protein G-affinity chromatography [22] . The doses used have been widely
Semiquantitative reverse-transcription (RT)-PCR
RNA was isolated and reverse-transcribed after removing contaminating genomic DNA by DNase I, as previously described [20] . The cDNA was 210g diluted in DEPCtreated H2O. The separate dilutions were each subjected to PCR as described [24] . For amplification 35 cycles (1 min at 94 "C for denaturation, 2 min at 55 "C for primer annealing and 3 min at 72 "C for primer extension) were performed using a DNA thermal cycler (Perkin-Elmer Cetus, Norwalk, CT). Primer sets for IL-4 resulting in a 180-bp product [24] , IL-6 resulting in a 348-bp product [24] , IFN-y resulting in a 245-bp product [24] and hypoxanthine phosphatidyl ribosyltransferase (HPRT), a house keeping gene transcript resulting in a 176-bp product, [25] were used. Reversetranscribed DNase I-treated CDC35 RNA and D1.1 RNA were used as positive control for Th2 and Thl cytokines, respectively. Both were a kind gift of Dr. D. C. Parker and were maintained as previously described [26] . After amplification the reaction products were electrophorated in 2 YO SeaKem LE agarose (FMC BioProducts, Rockland, ME). After staining with ethidium bromide the gels were photographed, and the photographs were subsequently scanned with a model 620 Video Densitometer (Bio-Rad Laboratories Inc., Hercules, CA) .The reverse-transcribed mRNA amounts in the two cDNA preparations were compared in the linear part of the cDNA dilution curve, and were expressed as dilution of cDNA to obtain a similar optical density.
Adoptive transfer of spleen cells
Spleens cells (1 X lo7) of mice, primed with TNP-KLH 3 months before, were adoptively transferred into naive irradiated (6 Gy) recipients as previously described [15] . All reconstituted mice were i.p. immunized with 10 pg TNP-KLH adsorbed on alum immediately after transfer.
T cell membrane stimulation
Spleen cells were cytotoxically depleted of T cells using anti-Thy-1.2 (clone F7D5; Serotec, Oxford, GB) and low-tox guinea pig complement (Cederlane, Hornby, Ontario, Canada) as described previously [16] . The percentage of B220+ B cells was routinely > 90%, while the percentage of residual Thy-l+ cells was < 2%, as determined by flow cytometry.ViableT cell-depleted spleen cells at 2.5 x lo5 celldm1 were cultured in flat-bottom microtiter plates together with 100 yg/ml T cell membrane fragments of activated H66 cells (Thl clone), a kind gift of Dr. l? D. Hodgkin [27, 281 in 0.2 ml complete RPMI 1640 medium supplemented with 10 YO heat-inactivated FCS, 2 mM glutamine, 0.1 M pyruvate, 100 IU/ml penicillin, 50 pg/ml streptomycin, 50 phf 2-mercaptoethanol, 35 ng/ml purified IL-4, 1.75 nglml purified IL-5 and 5 pg/ml antiIFNy (XMG 1.2) [29] . The cultures contained murine recombinant IL-6 (British Bio-technology Limited, Oxford, GB) 100IU/ml as indicated in the results section. Cultures which did not contain membrane fragments of activated H66 cells served as controls. After 7 days of culture at 5 YO COz and 37 "C supernatants were harvested for ELISA.
Results
Cytokine mRNA expression in the spleen during a primary IgE response
In this study we were interested in the involvement of E -4 and IL-6 in IgGl and IgE responses. Therefore, we investigated the cytokine mRNA expression in the spleen during a primary response against TNP-KLH, which predominantly induces IgGl and IgE responses in the given dose and the adjuvant employed. At days 0,2,4,6, and 8 after immunization mRNA was isolated from the spleens and after DNase I treatment RT-PCR was performed. Maximum IL-4 and IL-6 mRNA expressions were seen at day 2 after immunization, whereas IFN-y mRNA expression peaked at day6 ( Fig. 1 ). Moreover, it was found that the mRNA levels for IL-6 and IFN-y were significant higher than those for IL-4. For IFN-y mRNA a higher baseline level was observed when compared to the mRNA baseline levels for IL-4 and IL-6.The largest increase was seen for IL-4 mRNA expression (ninefold), whereas the mRNA levels for both IL-6 and IFN-y increased twofold ( Fig. 1 ). These results point to an important role of IL-4 and IL-6 in inducing IgGl and IgE responses upon TNP-KLH immunization.
Involvement of IL-4 and IL-6 in TNP-KLH-induced immune responses
Because of these results and former observations [lo, 121 we decided to examine the involvement of both IL-4 and IL-6 in primary IgGl and IgE responses more closely. To this end, mice were treated with neutralizing antibodies directed to IL-4 and IL-6 prior to immunization with 10 pg/ml TNP-KLH, by implanting i.p. alginate-encapsulated 11B11 cells, which produce anti-IL-4 antibodies, and 20F3 cells, which produce anti-IL-6 antibodies. Both l l B l l and 20F3 are of rat origin, and produce antibodies of the IgGl isotype. Alginate-encapsulated GL113 cells producing rat IgGl antibodies directed to E. coli P-galactosidase served as isotype control. At day 21 maximum total IgGl and IgE responses were observed in the serum of immunized mice treated with control antibody, 4.8 mg/ml and 4.1 pglml, respectively (Fig. 2) . Treatment of mice with anti-IL-4 completely abolished the increase in serum total IgE, whereas this treatment did not affect the increase in serum total IgG1.Treatment with anti-IL-6 had an opposite effect on these two isotypes. It did not disturb the IgE response, whereas it inhibited the increase in serum total
IgGl by 66 YO (Fig. 2) . For total serum IgE it was observed that the combination of encapsulated anti-11-4-producing l l B l l and anti-IL-6-producing 20F3 cells decreased the serum level below the day 0 level, indicating an effect on the background production (Fig. 2) .
With respect to the TNP-specific IgGl serum levels, other patterns were observed.These responses peaked at day 14.
It was observed that neutralization of 1L-6 alone did not inhibit the increase of TNP-specific serum IgGl(l44 pg/ml at day 0 to 455 pg/ml on day 14). The increase in TNPspecific IgGl was inhibited by 80 % by treating mice with a combination of encapsulated l l B l l and 20F3 cells. At day 21 no significant inhibition was observed in this situation (data not shown).The production of anti-cytokine mAb by the encapsulated cells was monitored by measuring rat IgGl in the serum of the mice in which they were implanted i.p. At day 7,87 pg/ml, 108 pg/ml319 pg/ml and 675 p g / d rat IgGl was observed in animals treated with GL113, 11B11, 20F3 or l l B l l together with 20F3 cells encapsulated in alginate, respectively (data not shown). After day 14 a decline in these rat IgGl serum levels was observed.This decline could explain the difference between theTNP-specific IgGl serum levels found on day 14 and 21 in mice that were implanted i.p. with both encapsulated 11B11 and 20F3 cells.
Involvement of IL-4 and IL-6 in GAM IgD-induced immune responses
The results found with respect to the TNP-KLH immunization suggested that IL-6 had a more important role in polyclonal IgGl responses than in antigen-specific primary IgGl responses. To study this role more precisely we immunized mice with 800 pg GAM IgD i.v. which is known to elicit strong polyclonal IgGl and IgE responses [30] . Immunization of mice resulted in an increase in the serum of 24 mg/ml for total IgGl and 4 pg/ml for total IgE at day 7 ( Fig. 3) . As in the TNP-KLH response, treatment of mice with alginate-encapsulated anti-11-4-producing 11B 11 cells completely abolished the IgE response in serum, but in this experiment inhibition (42 %) of the IgGl response was also observed (Fig. 3) . Neutralization of IL-6 by treating mice with 20F3 cells encapsulated in alginate inhibited the increase in serum total IgGl by 80 % , resulting in a serum level of total IgGl of 6 mg/ml (Fig. 3) . The increase in serum total IgE was not influenced by this treatment. Moreover, no synergistic effect was seen for anti-IL-4 mAb and anti-IL-6 mAb in the GAM IgD-induced IgGl response (Fig. 3) . GAM IgD injection neither induced an IgM nor an IgG2, response, showing the isotype specificity of the induced response. These responses were not changed by the various anti-cytokine treatments (Fig. 3) .
Involvement of IL-6 in an Nb-induced IgE response
We next used a Nb infection model to study the effects of neutralizing IL-4 and/or IL-6 on the induction of a different, but also strong, polyclonal IgE response. Nb infection induced an increase in the total serum IgE level from 1.5 pg/ml on day 0 to 41.9 pg/ml on day 11. Neutralizing IL-4 with 10 mg purified l l B l l inhibited the IgE response by 97%, whereas neutralizing IL-6 resulted in a 40% inhibition of the IgE increase (Table 1) . These results indicate an involvement of IL-6 in obtaining a strong polyclonal increase in IgE. To study whether IL-4 and IL-6 worked synergystically in this response, an experiment was performed in which IL-4 was suboptimally neutralized
(1 mg 1 l B l l i.p.), resulting in a 63 YO inhibition. Neutralization of IL-6 at the same time did not increase the percentage of inhibition (Table l) , indicating that IL-4 and IL-6 do not synergize in this polyclonal IgE response.
IgGl production by naive B cells stimulated with T cell membrane fragments is not potentiated by IL-6
To study whether IL-6 can potentiate IgGl production by naive B cells we performed in vitro experiments in which naive splenic B cells were polyclonally stimulated with membrane fragments of activated Thl cells in the presence or absence of exogenous IL-6. IL-4, IL-5 and anti-IFN-y were present in all cultures to facilitate optimal responses [27, 28] . Addition of IL-6 neither enhanced nor inhibited the production of IgGl and IgE during the 7 days of culture (Fig. 4) . In both stimulation conditions similar amounts of IgGl and IgE were produced; 20 pg/ml and 2.8 pg/ml, respectively. This result indicated that enough IL-6 was present in the culture system to facilitate peak IgGl and IgE production by naive B cells upon polyclonal stimulation.
Figure 4. Thy-1-depleted spleen cells of naive mice were stimulated withT cell membrane fragments of activated T h l cells (TM) in the presence or absence of IL-6. At day 7 the supernatants were harvested and the total IgGl and IgE levels determined. Results are expressed as arithmetic mean f SD (n = 5).
Involvement of IL-4 and IL-6 in memory IgGl and IgE responses
We next studied the involvement of IL-4 and IL-6 in the memory TNP-specific IgGl and IgE responses. For this, BALB/c mice that had been primed with 10 pg TNP-KLH adsorbed on alum 3 months before were boosted with 10 pg TNP-KLH adsorbed on alum. MaximumTNP-specific IgGl responses were seen on day 7, whereas a maximum TNPspecific IgE response was already observed on day5 (Fig. 5) . This TNP-specific IgE response was neither inhibited by either anti-IL-4 or anti-11-6 alone, nor by the combination of these two anti-cytokine mAb. Treatment was performed by implantation of alginate-encapsulated anti-cytokine mAb-producing hybridoma cells. At day 5 the rat IgGl serum levels of mice implanted with encapsulated GL113, 11B11, 20F3 or l l B l l combined with 20F3 cells were determined and found to be 185 pg/ml, 149 pg/ml, 320 pg/ml and 397 pg/ml, respectively. On day 7 the 108 pg/ml rat IgGl measured in serum of mice implanted with in alginate-encapsulated anti-IL-4-producing l l B l l cells completely abolished the primary IgE response. Anti-IL-4 and anti-IL-6 treatment inhibited the TNP-specific IgGl response on day 7 by 34 YO and 23 YO, respectively. When these two treatments were combined, the TNP-specific IgGl response was inhibited by 57 YO,
indicating that both IL-4 and IL-6 are required for an optimal memory TNP-specific IgGl response (Fig. 5 ).
T T 
Effect of neutralization of IL-4 and IL-6 on memory B cells to become IgGl or IgE-secreting plasma cells
In other studies we have shown that adoptive transfer of primed spleen cells to irradiated control mice leads to enhanced memory IgGl and IgE responses after boosting the reconstituted mice [15] . Therefore, we reconstituted 6
Gy-irradiated mice with 1 x lo7 TNP-KLH primed spleen cells and studied the effect of neutralizing IL-4 and IL-6 by injecting mice i.p. with 10 mg anti-IL-4, 10 mg anti-IL-4 + 2 mg anti-IL-6. Previously, IL-5 was reported to have an important role in inducing IgG1-positive B cells to secrete IgGl [31] . For this reason we also studied the involvement of both IL-5 and IL-6 in memory IgGl and IgE responses in serum IgE, whereas it did not result in an inhibition of the increase in total serum IgG1, an effect that has been well documented by us and other investigators [15, 30, 321 . However, we found that IgGl and IgE responses also differ in their need for IL-6 to obtain peak levels after primary immunization with TNP-KLH. Neutralization of IL-6 resulted in an inhibition of total serum IgGl, whereas it did not have any effect on the induced total serum IgE response. No inhibition of the increase in antigen-specific IgGl was observed as result of IL-6 neutralization, but neutralization of both IL-4 and IL-6 resulted in 80% inhibition of the antigen-specific IgGl response. This suggests that polyclonal IgGl responses are more dependent on IL-6 than antigen-specific IgGl responses, most likely as the result of preactivated B cells that only need IL-6 to become IgG1-secreting plasma cells. Moreover, with respect to IL-4 the opposite can be concluded in that antigen-specific IgGl responses are more dependent on IL-4 than polyclonal IgGl responses, suggesting that the polyclonal response originates from B cells already switched to IgGl. The induction of an IgE response, both antigen specific and polyclonal, could be inhibited by neutralizing IL-4, whereas neutralization of IL-6 did not have such effect. Furthermore, no synergistic effects were observed with respect to inhibition of polyclonal and antigen-specific IgE responses, when both IL-4 and IL-6 were neutralized. (Fig. 6 ). Neutralization of both IL-5 and IL-6 significantly inhibited the IgGl memory response by 52 YO .This treatment did not influence the memory IgE response (Fig. 6 ). No synergistic effect was observed for IG4 and IL-6 with respect to the memory IgE response, suggesting that also in the memory response no IL-6 is required for IgE production, even not in the absence of IL-4.
Discussion
This study shows that murine IgGl and IgE responses differ in their requirement for IL-6 in reaching peak levels. Neutralization of IL-6 resulted in inhibition of polyclonal Ig GI responses. Primary and memory antigen-specific IgGl responses were slightly inhibited by neutralizing IL-6, but neutralization of both IL-4 and IL-6 resulted in a marked decrease. These results show that these two cytokines act synergystically during a primary and memory antigenspecific IgGl responses. However, IL-6 neutralization did not inhibit antigen-specific and polyclonal IgE responses both after primary and secondary immunization. For human B cells a synergistic effect of IL-6 in combination with IL-4 in generating IgE has been described, by showing that anti-IL-6 antibodies strongly inhibited the IL-4-dependent IgE production in vitro [ 10, 111 . In mice we did not observe such synergistic effect. Therefore, we conclude that murine B cells and human B cells differ with respect to the need for IL-6 to give rise to peak levels of IgE.
Neutralization of IL-4 after primary immunization with TNP-KLH resulted in an abrogation of the increase in total To study the involvement of IL-4 and IL-6 in a strong polyclonal response we did experiments in which we used GAM IgD to evoke large polyclonal IgGl and IgE responses in vivo [30] . The GAM IgD-induced serum peak IgGl levels could be inhibited for 80% by neutralizing IL-6, indicating that IL-6 is important for the induction. As expected, the induced increase in total serum IgE could be completely inhibited by neutralizing IL-4. No inhibition of the IgE response was found upon neutralizing IL-6. Also in the GAM IgD-induced response no synergistic effect was found when both IL-4 and IL-6 were neutralized. Two possibilities can account for this new phenomenon. It has been described that IL-6 is required for terminal differentiation of B cells to Ig-secreting plasma cells [34] . that both the IgGl and IgE production were not influenced by exogenous IL-6. It is possible that no enhancement by IL-6 is observed because enough endogenous IL-6 is produced in the in vitro cultures to obtain peak production. Nevertheless, this study makes clear that neither the IgGl nor the IgE production is inhibited by exogenous IL-6.
For Mesocestoides corti-infected mice it was described that neutralization of IL-6 resulted in a marked inhibition of the IgGl serum levels, which are known to increase as result of infection [36] . This is in line with our results. However, M. corti infection does not lead to an increase in serum IgE.
Therefore, it could not be determined whether I C 6 was necessary for peak IgE responses upon parasite infection.
In this study we show that IL-6 in part is necessary for the large increase in polyclonal IgE responses after infection with Nb. However, no synergistic effect of neutralizing I L 4 and IL-6 with respect to the inhibition of the IgE response was seen when IL-4 was suboptimally neutralized.
We also examined the IL-6 dependence of antigen-specific IgGl memory responses, because it was shown by Hilbert et al. [37] that primary influenza virus-specific antibody responses were IL-6 dependent, whereas secondary antigen-specific antibody responses were IL-6 independent. In that study, however, no distinction has been made between the individual isotype responses that account for the antigen-specific antibody responses after priming and boosting with the antigen. In our study no difference was seen with respect to IL-6 dependence between the antigenspecific primary and memory IgGl response. For the antigen-specific memory IgGl response no synergistic effect was observed when both IG4 and IL-6 were neutralized. As found in former studies, the antigen-specific memory IgE response was not completely inhibited by neutralizing IL-4. However, the amount of anti-IL-4 antibody present in the serum of treated mice was sufficient to completely inhibit the primary IgE response. Hence, it is possible that the amount of anti-IL-4 antibodies present in the serum is not enough to completely neutralize IL-4 after secondary immunization. This in combination with a decreased IL-4 dependence of memory B cells to secrete IgE could account for a normal antigen-specific IgE response after secondary immunization.
The adoptive transfer experiments were performed because it is known that in this sort of experiments upon boosting the secondary IgE responses are preferentially enhanced [15, 38] . In these experiments, it was found that only neutralizing IL-4 inhibited the memory IgE response, leaving 10% of the response intact. This part of the response is also independent of IL-6, and is most likely the result of B cells switched to IgE. In addition, neutralization of both IL-5 and IL-6 did not influence the IgE memory response, whereas it did inhibit the IgGl memory response, showing that both IL-5 and 1L-6 are involved in the IgGl, but not the IgE memory response.
Collectively, these results show that IgGl and IgE responses, both primary and secondary, differ in IL-6 dependence.
Whereas IgGl responses are inhibited in vivo by neutralizing IL-6, IgE responses are not influenced. The difference in IL-6 necessity to obtain peak IgGl and IgE responses provides a new regulatory mechanism, besides IL-4, for the murine IgGl and IgE responses coupled to each other by sequential isotype switching.
